AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
AVEO Oncology (AVEO) Fails to deliver data
Key failure to deliver metrics for AVEO Oncology :
- Last SEC data release: 2023-12-29
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.04 M
Failures to deliver for AVEO Oncology (AVEO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for AVEO Oncology (AVEO) - since 2020
Volume in USD (price x number of shares), data since 2020AVEO Oncology (AVEO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $0.04 M | -99.6% |
| 2022 | $12.53 M | -34.99% |
| 2021 | $19.27 M | 100.09% |
| 2020 | $9.63 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $59.04 M | $0.14 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.1 M | $0.98 M | 🇺🇸 USA |